Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference35 articles.
1. Liver cancer incidence and mortality in China: Temporal trends and projections to 2030;Zheng;Chin J Cancer Res,2018
2. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus ( 2018);Cheng;J Clin Hepatol,2019
3. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients;Pawarode;Am J Clin Oncol,1998
4. Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma;Zhao;J Gastrointestinal Surgery,2016
5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of the Efficacy and Safety of Transarterial Chemoembolization Plus Microwave Ablation versus Surgical Resection in Patients with Solitary Large Hepatocellular Carcinoma: A Propensity Score-Matched Analysis;Journal of Hepatocellular Carcinoma;2022-12
2. Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence–Based Decision-Making Tool;JCO Clinical Cancer Informatics;2022-06
3. Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)–Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study;CardioVascular and Interventional Radiology;2022-04-11
4. A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells;Frontiers in Pharmacology;2022-03-23
5. Percutaneous treatments of hepatocellular carcinoma: Improving efficacy, applicability and extending ablation criteria;Liver Cancer International;2022-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3